The Scientist Logo_white

Advancing Drug Discovery with Protein Degrader Screens

Researchers use an automated immunoassay platform to analyze Degrader panels.

Logo on White


473x300 Laptop on F6F6F6

PROTAC® (PROteolysis TArgeting Chimeras) Degraders are small molecules that use the ubiquitin-proteasome system to selectively degrade target proteins within cells. To discover novel drugs, researchers use high-throughput platforms to screen large Degrader compound libraries. Scientists optimize their screens with an automated immunoassay platform that accurately quantifies degradation activity in less time and at a lower cost compared to traditional Western blots.

Download this application note from Protein Simple to learn how researchers utilize the Simple Western platform to design and optimize targeted protein degradation strategies.


PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license